 | • レポートコード：MRC2-11QY04260 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はフェニルケトン尿症治療のグローバル市場について調査・分析したレポートです。種類別（薬物、栄養補助食品）市場規模、用途別（病院薬局、ドラッグストア、オンライン薬局、小児科クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別フェニルケトン尿症治療の競争状況、市場シェア ・世界のフェニルケトン尿症治療市場：種類別市場規模 2015年-2020年（薬物、栄養補助食品） ・世界のフェニルケトン尿症治療市場：種類別市場規模予測 2021年-2026年（薬物、栄養補助食品） ・世界のフェニルケトン尿症治療市場：用途別市場規模 2015年-2020年（病院薬局、ドラッグストア、オンライン薬局、小児科クリニック） ・世界のフェニルケトン尿症治療市場：用途別市場規模予測 2021年-2026年（病院薬局、ドラッグストア、オンライン薬局、小児科クリニック） ・北米のフェニルケトン尿症治療市場分析：米国、カナダ ・ヨーロッパのフェニルケトン尿症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのフェニルケトン尿症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のフェニルケトン尿症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのフェニルケトン尿症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：American Gene Technologies、Dimension Therapeutics、BioMarin Pharmaceutical、Synthetic Biologics、Codexis、SOM Innovation Biotech、Daiichi Sankyo、Erytech Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Phenylketonuria is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine.
The key factor contributing to the phenylketonuria treatment market is the increasing incidence of phenylketonuria.
Market Analysis and Insights: Global Phenylketonuria Treatment Market
The global Phenylketonuria Treatment market size is projected to reach US$ 427.2 million by 2026, from US$ 400.2 million in 2020, at a CAGR of 6.2%% during 2021-2026.
Global Phenylketonuria Treatment Scope and Market Size
Phenylketonuria Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Phenylketonuria Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
American Gene Technologies
Dimension Therapeutics
BioMarin Pharmaceutical
Synthetic Biologics
Codexis
SOM Innovation Biotech
Daiichi Sankyo
Erytech Pharma
Market segment by Type, the product can be split into
Drugs
Dietary Supplement
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Online Pharmacies
Pediatric Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Phenylketonuria Treatment Revenue
1.4 Market by Type
1.4.1 Global Phenylketonuria Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Dietary Supplement
1.5 Market by Application
1.5.1 Global Phenylketonuria Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Online Pharmacies
1.5.5 Pediatric Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Phenylketonuria Treatment Market Perspective (2015-2026)
2.2 Global Phenylketonuria Treatment Growth Trends by Regions
2.2.1 Phenylketonuria Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Phenylketonuria Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Phenylketonuria Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Phenylketonuria Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Phenylketonuria Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Phenylketonuria Treatment Players by Market Size
3.1.1 Global Top Phenylketonuria Treatment Players by Revenue (2015-2020)
3.1.2 Global Phenylketonuria Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Phenylketonuria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Phenylketonuria Treatment Market Concentration Ratio
3.2.1 Global Phenylketonuria Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Phenylketonuria Treatment Revenue in 2019
3.3 Phenylketonuria Treatment Key Players Head office and Area Served
3.4 Key Players Phenylketonuria Treatment Product Solution and Service
3.5 Date of Enter into Phenylketonuria Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Phenylketonuria Treatment Historic Market Size by Type (2015-2020)
4.2 Global Phenylketonuria Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Phenylketonuria Treatment Market Size by Application (2015-2020)
5.2 Global Phenylketonuria Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Phenylketonuria Treatment Market Size (2015-2020)
6.2 Phenylketonuria Treatment Key Players in North America (2019-2020)
6.3 North America Phenylketonuria Treatment Market Size by Type (2015-2020)
6.4 North America Phenylketonuria Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Phenylketonuria Treatment Market Size (2015-2020)
7.2 Phenylketonuria Treatment Key Players in Europe (2019-2020)
7.3 Europe Phenylketonuria Treatment Market Size by Type (2015-2020)
7.4 Europe Phenylketonuria Treatment Market Size by Application (2015-2020)
8 China
8.1 China Phenylketonuria Treatment Market Size (2015-2020)
8.2 Phenylketonuria Treatment Key Players in China (2019-2020)
8.3 China Phenylketonuria Treatment Market Size by Type (2015-2020)
8.4 China Phenylketonuria Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Phenylketonuria Treatment Market Size (2015-2020)
9.2 Phenylketonuria Treatment Key Players in Japan (2019-2020)
9.3 Japan Phenylketonuria Treatment Market Size by Type (2015-2020)
9.4 Japan Phenylketonuria Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Phenylketonuria Treatment Market Size (2015-2020)
10.2 Phenylketonuria Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Phenylketonuria Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Phenylketonuria Treatment Market Size by Application (2015-2020)
11 India
11.1 India Phenylketonuria Treatment Market Size (2015-2020)
11.2 Phenylketonuria Treatment Key Players in India (2019-2020)
11.3 India Phenylketonuria Treatment Market Size by Type (2015-2020)
11.4 India Phenylketonuria Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Phenylketonuria Treatment Market Size (2015-2020)
12.2 Phenylketonuria Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Phenylketonuria Treatment Market Size by Type (2015-2020)
12.4 Central & South America Phenylketonuria Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 American Gene Technologies
13.1.1 American Gene Technologies Company Details
13.1.2 American Gene Technologies Business Overview
13.1.3 American Gene Technologies Phenylketonuria Treatment Introduction
13.1.4 American Gene Technologies Revenue in Phenylketonuria Treatment Business (2015-2020))
13.1.5 American Gene Technologies Recent Development
13.2 Dimension Therapeutics
13.2.1 Dimension Therapeutics Company Details
13.2.2 Dimension Therapeutics Business Overview
13.2.3 Dimension Therapeutics Phenylketonuria Treatment Introduction
13.2.4 Dimension Therapeutics Revenue in Phenylketonuria Treatment Business (2015-2020)
13.2.5 Dimension Therapeutics Recent Development
13.3 BioMarin Pharmaceutical
13.3.1 BioMarin Pharmaceutical Company Details
13.3.2 BioMarin Pharmaceutical Business Overview
13.3.3 BioMarin Pharmaceutical Phenylketonuria Treatment Introduction
13.3.4 BioMarin Pharmaceutical Revenue in Phenylketonuria Treatment Business (2015-2020)
13.3.5 BioMarin Pharmaceutical Recent Development
13.4 Synthetic Biologics
13.4.1 Synthetic Biologics Company Details
13.4.2 Synthetic Biologics Business Overview
13.4.3 Synthetic Biologics Phenylketonuria Treatment Introduction
13.4.4 Synthetic Biologics Revenue in Phenylketonuria Treatment Business (2015-2020)
13.4.5 Synthetic Biologics Recent Development
13.5 Codexis
13.5.1 Codexis Company Details
13.5.2 Codexis Business Overview
13.5.3 Codexis Phenylketonuria Treatment Introduction
13.5.4 Codexis Revenue in Phenylketonuria Treatment Business (2015-2020)
13.5.5 Codexis Recent Development
13.6 SOM Innovation Biotech
13.6.1 SOM Innovation Biotech Company Details
13.6.2 SOM Innovation Biotech Business Overview
13.6.3 SOM Innovation Biotech Phenylketonuria Treatment Introduction
13.6.4 SOM Innovation Biotech Revenue in Phenylketonuria Treatment Business (2015-2020)
13.6.5 SOM Innovation Biotech Recent Development
13.7 Daiichi Sankyo
13.7.1 Daiichi Sankyo Company Details
13.7.2 Daiichi Sankyo Business Overview
13.7.3 Daiichi Sankyo Phenylketonuria Treatment Introduction
13.7.4 Daiichi Sankyo Revenue in Phenylketonuria Treatment Business (2015-2020)
13.7.5 Daiichi Sankyo Recent Development
13.8 Erytech Pharma
13.8.1 Erytech Pharma Company Details
13.8.2 Erytech Pharma Business Overview
13.8.3 Erytech Pharma Phenylketonuria Treatment Introduction
13.8.4 Erytech Pharma Revenue in Phenylketonuria Treatment Business (2015-2020)
13.8.5 Erytech Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Phenylketonuria Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Phenylketonuria Treatment Revenue
Table 3. Ranking of Global Top Phenylketonuria Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Phenylketonuria Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Dietary Supplement
Table 7. Global Phenylketonuria Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Phenylketonuria Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Phenylketonuria Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Phenylketonuria Treatment Market Share by Regions (2015-2020)
Table 11. Global Phenylketonuria Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Phenylketonuria Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Phenylketonuria Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Phenylketonuria Treatment Players
Table 18. Global Phenylketonuria Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Phenylketonuria Treatment Market Share by Players (2015-2020)
Table 20. Global Top Phenylketonuria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phenylketonuria Treatment as of 2019)
Table 21. Global Phenylketonuria Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Phenylketonuria Treatment Product Solution and Service
Table 24. Date of Enter into Phenylketonuria Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Phenylketonuria Treatment Market Size Share by Type (2015-2020)
Table 28. Global Phenylketonuria Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Phenylketonuria Treatment Market Size Share by Application (2015-2020)
Table 30. Global Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Phenylketonuria Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 34. North America Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 36. North America Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 40. Europe Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 42. Europe Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 46. China Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 48. China Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 52. Japan Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 54. Japan Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 58. Southeast Asia Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 64. India Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 66. India Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Phenylketonuria Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Phenylketonuria Treatment Market Share (2019-2020)
Table 70. Central & South America Phenylketonuria Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Phenylketonuria Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Phenylketonuria Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Phenylketonuria Treatment Market Share by Application (2015-2020)
Table 74. American Gene Technologies Company Details
Table 75. American Gene Technologies Business Overview
Table 76. American Gene Technologies Product
Table 77. American Gene Technologies Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 78. American Gene Technologies Recent Development
Table 79. Dimension Therapeutics Company Details
Table 80. Dimension Therapeutics Business Overview
Table 81. Dimension Therapeutics Product
Table 82. Dimension Therapeutics Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 83. Dimension Therapeutics Recent Development
Table 84. BioMarin Pharmaceutical Company Details
Table 85. BioMarin Pharmaceutical Business Overview
Table 86. BioMarin Pharmaceutical Product
Table 87. BioMarin Pharmaceutical Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 88. BioMarin Pharmaceutical Recent Development
Table 89. Synthetic Biologics Company Details
Table 90. Synthetic Biologics Business Overview
Table 91. Synthetic Biologics Product
Table 92. Synthetic Biologics Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 93. Synthetic Biologics Recent Development
Table 94. Codexis Company Details
Table 95. Codexis Business Overview
Table 96. Codexis Product
Table 97. Codexis Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 98. Codexis Recent Development
Table 99. SOM Innovation Biotech Company Details
Table 100. SOM Innovation Biotech Business Overview
Table 101. SOM Innovation Biotech Product
Table 102. SOM Innovation Biotech Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 103. SOM Innovation Biotech Recent Development
Table 104. Daiichi Sankyo Company Details
Table 105. Daiichi Sankyo Business Overview
Table 106. Daiichi Sankyo Product
Table 107. Daiichi Sankyo Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 108. Daiichi Sankyo Recent Development
Table 109. Erytech Pharma Business Overview
Table 110. Erytech Pharma Product
Table 111. Erytech Pharma Company Details
Table 112. Erytech Pharma Revenue in Phenylketonuria Treatment Business (2015-2020) (Million US$)
Table 113. Erytech Pharma Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phenylketonuria Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Dietary Supplement Features
Figure 4. Global Phenylketonuria Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Drug Stores Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Pediatric Clinics Case Studies
Figure 9. Phenylketonuria Treatment Report Years Considered
Figure 10. Global Phenylketonuria Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Phenylketonuria Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Phenylketonuria Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Phenylketonuria Treatment Market Share by Players in 2019
Figure 15. Global Top Phenylketonuria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phenylketonuria Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Phenylketonuria Treatment Revenue in 2019
Figure 17. North America Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Phenylketonuria Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…- 小児神経芽細胞腫治療の世界市場（～2026年） In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market size is…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 消化器疾患治療 の世界市場（～2026年） Digestive distress treatment comprises of the treatment of liver and digestive tract diseases this comprises of stomach, gallbladder, pancreas, colon, duodenum, biliary tract, small intestine, and others. According to the study conducted by Scleroderma Foundation in 2014, after skin, the digestive s…